{
    "paper_id": "551551b6447642735b59a49cbaa78a7b149b54d4",
    "metadata": {
        "title": "Sup Table 2. Potential drug targets expressed by the host cell or secreted by Leishmania. Category Molecular effector Reference",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Host immune response retinoid X receptor alpha, deubiquitinating enzyme A20, CTLA-4, Programed Death-1, CD200R, TIM-3, miR122 or Dicer molecules, proinflammatory cytokines and chemokines (1) (2) (3) (4) (5) (6) Host cell viability host myeloid cell leukemia 1 factor shRNA (7 ",
            "cite_spans": [
                {
                    "start": 187,
                    "end": 190,
                    "text": "(1)",
                    "ref_id": null
                },
                {
                    "start": 191,
                    "end": 194,
                    "text": "(2)",
                    "ref_id": null
                },
                {
                    "start": 195,
                    "end": 198,
                    "text": "(3)",
                    "ref_id": null
                },
                {
                    "start": 199,
                    "end": 202,
                    "text": "(4)",
                    "ref_id": null
                },
                {
                    "start": 203,
                    "end": 206,
                    "text": "(5)",
                    "ref_id": null
                },
                {
                    "start": 207,
                    "end": 210,
                    "text": "(6)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mukherjee",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mukherjee",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mukhopadhyay",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Naskar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sundar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Dujardin",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Immunol",
            "volume": "193",
            "issn": "8",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.1400710"
                ],
                "PMID": [
                    "25217162"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Rachidi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Taly",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Durieu",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Leclercq",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Aulner",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Prina",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antimicrob Agents Chemother",
            "volume": "58",
            "issn": "3",
            "pages": "1501--1516",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.02022-13"
                ],
                "PMID": [
                    "24366737"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Intracellular targets of cyclindependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Knockaert",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Gray",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Damiens",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Grellier",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Grant",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Chem Biol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Durieu",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Prina",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Leclercq",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Oumata",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Gaboriaud-Kolar",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Vougogiannopoulou",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Isoform 2 To Identify Compounds with Antileishmanial Activity",
            "authors": [],
            "year": 2016,
            "venue": "Antimicrob Agents Chemother",
            "volume": "60",
            "issn": "5",
            "pages": "2822--2855",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.00021-16"
                ]
            }
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Singh R, Nakhasi HL. Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules. Front Immunol. current status and future prospects. Front Immunol. 2014;5:296. doi: 10.3389/fimmu.2014.00296. http://www.ncbi.nlm.nih.gov/pubmed/25183962. PMID:25183962 3. Roatt BM, Aguiar-Soares RD, Coura-Vital W, Ker HG, Moreira N, Vitoriano-Souza J, et al. Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease. Front Immunol. 2014;5:272. doi: 10.3389/fimmu.2014.00272. http://www.ncbi.nlm.nih.gov/pubmed/24982655. PMID:24982655 4. Beattie L, d'El-Rei Hermida M, Moore JW, Maroof A, Brown N, Lagos D, et al. A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Chande AG, Mukhopadhyaya R, Das PK. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response. J Immunol. 2012 Jul 15;189(2):924-34. doi: 10.4049/jimmunol.1102845. http://www.ncbi.nlm.nih.gov/pubmed/22685311. PMID:22685311 6. Ghosh J, Bose M, Roy S, Bhattacharyya SN. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe. 2013 Mar 13;13(3):277-88. doi: 10.1016/j.chom.2013.02.005. http://www.ncbi.nlm.nih.gov/pubmed/23498953. PMID:23498953 7. Giri J, Srivastav S, Basu M, Palit S, Gupta P, Ukil A. Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis. J Biol Chem. 2016 Feb 12;291(7):3496-507. doi: 10.1074/jbc.M115.672873. http://www.ncbi.nlm.nih.gov/pubmed/26670606. Dillon LA, Suresh R, Okrah K, Corrada Bravo H, Mosser DM, El-Sayed NM. Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions. http://www.ncbi.nlm.nih.gov/pubmed/26715493. PMID:26715493 11. Marr AK, MacIsaac JL, Jiang R, Airo AM, Kobor MS, McMaster WR. Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. PLoS Pathog. 2014 Oct;10(10):e1004419. doi: 10.1371/journal.ppat.1004419. http://www.ncbi.nlm.nih.gov/pubmed/25299267. PMID:25299267",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}